Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):313-25. doi: 10.1586/erp.13.27.
Point of care (POC) diagnostics are often hailed as having the potential to transform tuberculosis (TB) control efforts. However, POC testing is better conceptualized as a system of diagnosis and treatment, not simply a test that can provide rapid, deployable results. Economic evaluations may help decision makers allocate scarce resources for TB control, but evaluations of POC testing face unique challenges that include evaluating the full diagnostic system, incorporating implementation costs, translating diagnostic results into health and accounting for downstream treatment costs. For economic evaluations to reach their full potential as decision-making tools for POC testing in TB, these challenges must be understood and addressed.
即时检测(POC)通常被认为有潜力改变结核病(TB)的防控工作。然而,POC 检测更应被视为一种诊断和治疗系统,而不仅仅是一种能够提供快速、可部署结果的检测手段。经济评估可能有助于决策者为结核病控制分配稀缺资源,但 POC 检测的评估面临着独特的挑战,包括评估整个诊断系统、纳入实施成本、将诊断结果转化为健康结果以及考虑下游治疗成本。为了使经济评估在作为 POC 检测决策工具方面充分发挥潜力,必须理解和解决这些挑战。